FIELD: pharmaceuticals.
SUBSTANCE: group of inventions relates to the field of chemical and pharmaceutical industry and medicine, namely to the dosage form of an antioxidant and antihypoxic agent in the form of a solution for injection, characterized by the fact that it includes 2-ethyl-6-methyl-3-hydroxypyridine succinate, a stabilizer representing 2-hydroxy-2-propanesulfonic acid monosodium salt and water for injection with the following content of components in wt. %: 2-ethyl-6-methyl-3-hydroxypyridine succinate 2.0-15.0; 2-hydroxy-2-propanesulfonic acid monosodium salt 0.01-0.4; water for injection being the rest. The use of 2-hydroxy-2-propanesulfonic acid monosodium salt as a stabilizer of a solution for injection containing 2-ethyl-6-methyl-3-hydroxypyridine succinate is also presented.
EFFECT: expansion of the arsenal of medicines with improved quality indicators: high stability and lower toxicity.
3 cl, 20 tbl
Authors
Dates
2021-09-13—Published
2020-11-12—Filed